EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Predictive Value of the KELIM Index for Progression-Free Survival in Ovarian Cancer Under Current Treatment Modalities

Jiajin Lv, Yunyi Xu, Chunyan Zeng, Fengyan Huang, Suping Tao

International Journal of Women's Health · 2025-07 · Volume 17 · 2291-2297

DOI: 10.2147/ijwh.s533323 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Women's Health, 2025-07. Verfasst von Jiajin Lv und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, The First Hospital of Jiaxing, Jiaxing, Zhejiang, People's Republic of China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The KELIM index, a dynamic biomarker derived from CA125 kinetics, has shown prognostic value in ovarian cancer. However, its predictive role under contemporary treatment paradigms incorporating bevacizumab and PARP inhibitors remains underexplored.

Objective

To evaluate the predictive value of the KELIM index for progression-free survival (PFS) in ovarian cancer patients treated with current therapeutic modalities.

Methods

A total of 52 patients with ovarian cancer who underwent surgical treatment in the Affiliated Hospital of Jiaxing University from January 1, 2020 to September 30, 2023 were retrospectively analyzed. Clinicopathological data, treatment details (including bevacizumab/PARPi use), and serial CA125 values were collected. The KELIM index was calculated using the online biomarker kinetics tool (https://www.biomarker-kinetics.org/CA125). Cox regression and Kaplan-Meier analyses assessed prognostic factors.

Results

The mean age of the 52 patients was 55.17±13.57 years, and the mean body mass index (BMI) was 22.95±3.62kg/m2. There were 35 cases (67.3%) in the KELIM index ≥1 group and 17 cases (32.7%) in the KELIM index < 1 group. Multivariate analysis identified KELIM index (HR=0.25, 95% CI 0.077-0.818, P

Schlagwörter

Stichwörter der Autor:innen

KELIM indexovarian cancerprogression-free survival

Autor:innen und Institutionen

  • Department of Gynecology, The First Hospital of Jiaxing, Jiaxing, Zhejiang, People's Republic of China.

Zitieren

APA

Lv, J., Xu, Y., Zeng, C., Huang, F., & Tao, S. (2025). Predictive Value of the KELIM Index for Progression-Free Survival in Ovarian Cancer Under Current Treatment Modalities. International Journal of Women's Health, Volume 17, 2291-2297. https://doi.org/10.2147/ijwh.s533323

Vancouver

Lv J, Xu Y, Zeng C, Huang F, Tao S. Predictive Value of the KELIM Index for Progression-Free Survival in Ovarian Cancer Under Current Treatment Modalities. International Journal of Women's Health. 2025;Volume 17:2291-2297. doi:10.2147/ijwh.s533323

BibTeX
@article{Lv2025,
  author = {Lv, Jiajin and Xu, Yunyi and Zeng, Chunyan and Huang, Fengyan and Tao, Suping},
  title = {Predictive Value of the KELIM Index for Progression-Free Survival in Ovarian Cancer Under Current Treatment Modalities},
  journal = {International Journal of Women's Health},
  year = {2025},
  volume = {Volume 17},
  pages = {2291--2297},
  doi = {10.2147/ijwh.s533323}
}
Kostenlos starten →